scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1002/BIES.950170606 |
P698 | PubMed publication ID | 7575491 |
P50 | author | Lynne S Cox | Q47503394 |
David P. Lane | Q909289 | ||
P2860 | cites work | Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen | Q24308837 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA damage | Q5205747 |
P304 | page(s) | 501-508 | |
P577 | publication date | 1995-06-01 | |
P1433 | published in | BioEssays | Q4914614 |
P1476 | title | Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage | |
P478 | volume | 17 |
Q34769941 | "Super p53" mice display retinal astroglial changes. |
Q28276061 | 14-3-3sigma is a p53-regulated inhibitor of G2/M progression |
Q42023227 | A drug-induced accelerated senescence (DIAS) is a possibility to study aging in time lapse. |
Q33890169 | A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. |
Q42482703 | A unique, short sequence determines p53 gene basal and UV-inducible expression in normal human cells |
Q41187291 | ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified |
Q35005862 | Age-related gene response of human corneal endothelium to oxidative stress and DNA damage. |
Q39311604 | Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation. |
Q48301862 | Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain |
Q48636604 | Apoptosis and protein expression after focal cerebral ischemia in rat. |
Q28570424 | Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis |
Q46442171 | Astrocytes Can Adopt Endothelial Cell Fates in a p53-Dependent Manner |
Q41183818 | Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints |
Q48482815 | BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study |
Q35917304 | Bax alpha perturbs T cell development and affects cell cycle entry of T cells |
Q41141483 | Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions |
Q41740220 | Biochemical and molecular mechanisms regulating apoptosis |
Q40737382 | C-terminus of p53 is required for G(2) arrest |
Q41099892 | Cdk inhibitors in development and cancer |
Q33870070 | Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alpha |
Q42860709 | Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. |
Q53444483 | Cell cycle effects and concomitant p53 expression in hairless murine skin after longwave UVA (365 nm) irradiation: a comparison with UVB irradiation. |
Q40526763 | Cells synchronized in S phase show increased rate of repair of UV damaged plasmids |
Q28611443 | Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM |
Q41081308 | Characterisation of genotoxic properties of 2',2'-difluorodeoxycytidine. |
Q36724291 | Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. |
Q35683292 | Comparing Two Intestinal Porcine Epithelial Cell Lines (IPECs): Morphological Differentiation, Function and Metabolism |
Q38316929 | DNA Structure and Polymerase Fidelity: A New Role for A-DNA. |
Q40261691 | DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1. |
Q36241935 | Development and progression of colorectal neoplasia |
Q33939756 | Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. |
Q41126128 | Early T-cell development in CD3-deficient mice. |
Q41157654 | Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells |
Q78177523 | Effect of p53 protein redox states on binding to supercoiled and linear DNA |
Q38323460 | Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments. |
Q52177924 | Effects of EGF and TGFbeta1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells. |
Q40257096 | Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line |
Q41172182 | Effects of ionizing- and UV B-radiation on proteins controlling cell cycle progression in human cells: comparison of the MCF-7 adenocarcinoma and the SCL-2 squamous cell carcinoma cell line |
Q28205889 | Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth |
Q77599042 | Electrochemical biosensors for DNA hybridization and DNA damage |
Q50152803 | Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas |
Q77331358 | Epidermal cell kinetics of pig skin in vivo following UVB irradiation: apoptosis induced by UVB is enhanced in hyperproliferative skin condition |
Q37593200 | Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors |
Q43681104 | Expression of Bcl-2 during the development of rabbit retina |
Q52163968 | Expression of bcl-2, bax, and caspase-3 in the brain of the developing rat. |
Q24633970 | FinO is an RNA chaperone that facilitates sense-antisense RNA interactions |
Q41099898 | From DNA damage to cell cycle arrest and suicide: a budding yeast perspective |
Q38356227 | Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. |
Q36561445 | Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo. |
Q22009111 | GADD45 induction of a G2/M cell cycle checkpoint |
Q48630368 | Granule cell apoptosis and protein expression in hippocampal dentate gyrus after forebrain ischemia in the rat. |
Q42996334 | Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma |
Q38502133 | High affinity MAR-DNA binding is a common property of murine and human mutant p53. |
Q35128610 | Implications of Genetic Testing in the Management of Colorectal Cancer |
Q34940163 | In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals |
Q40453300 | Inactivated MGMT by O6-benzylguanine is associated with prolonged G2/M arrest in cancer cells treated with BCNU. |
Q40878227 | Increase in ultraviolet sensitivity by overexpression of calpastatin in ultraviolet-resistant UVr-1 cells derived from ultraviolet-sensitive human RSa cells |
Q36565973 | Incubation at the nonpermissive temperature induces deficiencies in UV resistance and mutagenesis in mouse mutant cells expressing a temperature-sensitive ubiquitin-activating enzyme (E1) |
Q39432180 | Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231. |
Q48135741 | Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells. |
Q41684512 | Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli |
Q78171317 | Inhibition of RNA polymerase II as a trigger for the p53 response |
Q34283452 | Integration of the pRB and p53 cell cycle control pathways |
Q40141347 | KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation in vitro |
Q24655032 | Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage |
Q59098941 | Life (and death) in a malignant tumour |
Q33997297 | MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification |
Q33807844 | Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. |
Q44332743 | Metaplastic potential of p53 down-regulation in ovarian surface epithelial cells affected by ovulation |
Q29616465 | Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control |
Q41045031 | Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication |
Q41262814 | Molecular genetic approaches to non-melanoma and melanoma skin cancer |
Q34075825 | Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells |
Q41656068 | Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. |
Q41679282 | Nuclear and non-nuclear targets of genotoxic agents in the induction of gene expression. Shared principles in yeast, rodents, man and plants |
Q41485266 | Oncogenes and antioncogenes in the development of HPV associated tumors |
Q38472082 | Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy |
Q42282297 | P53 is required for the developmental restriction in Müller glial proliferation in mouse retina |
Q40637670 | Paradoxical homozygous expression from heterozygotes and heterozygous expression from homozygotes as a consequence of transcriptional infidelity through a polyadenine tract in the AP3B1 gene responsible for canine cyclic neutropenia. |
Q41510725 | Pathways of p53-dependent apoptosis. |
Q28269174 | Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions |
Q35764557 | Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities |
Q81251232 | Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer |
Q74841126 | Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection |
Q41583628 | Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology |
Q33285211 | Proteome analysis of proliferative response of bystander cells adjacent to cells exposed to ionizing radiation |
Q74355214 | RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome |
Q39720046 | Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice |
Q40958881 | Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2. |
Q39451635 | Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells |
Q29547667 | Requirement for p53 and p21 to sustain G2 arrest after DNA damage |
Q45760172 | Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein |
Q44448676 | Several regions of p53 are involved in repression of RNA polymerase III transcription |
Q39876425 | Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen. |
Q74754870 | Small-molecule-based strategies for controlling gene expression |
Q40396261 | Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. |
Q38355794 | Stress response of a p53 homologue in the radioresistant Sf9 insect cells. |
Q41462860 | Studies of neoplasia in the Min mouse |
Q40750476 | Study of the G2/M cell cycle checkpoint in irradiated mammary epithelial cells overexpressing Cul-4A gene |
Q31904803 | Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha |
Q41064142 | T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. |
Q73006646 | TATA-binding protein and the Gal4 transactivator do not bind to promoters cooperatively |
Q34015423 | Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function |
Q36280815 | Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. |
Q79272896 | The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer |
Q73975361 | The effects of acute ethanol exposure on inhibitors of hepatic regenerative activity in the rat |
Q34776139 | The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins |
Q73794128 | The p53/retinoblastoma-mediated repression of testicular orphan receptor-2 in the rhesus monkey with cryptorchidism |
Q36483126 | The role of DNA exonucleases in protecting genome stability and their impact on ageing. |
Q41193565 | The role of DNA repair in the prevention of cancer |
Q73707457 | The status of p53 in the metastatic progression of colorectal cancer |
Q36295120 | The ubiquitin-proteasome pathway in cancer |
Q42807014 | Three distinct signalling responses by murine fibroblasts to genotoxic stress |
Q34616640 | Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein |
Q36617345 | Tumour markers of prognosis in colorectal cancer |
Q36797206 | UV-B-induced cell cycle perturbations, micronucleus induction, and modulation by caffeine in human keratinocytes |
Q36564865 | Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation |
Q60221819 | c-Myc in the Controlm of Cell Proliferation and Embryonic Development |
Q58795101 | mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases |
Q28512737 | p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition |
Q71170481 | p53 Protein exhibits 3'-to-5' exonuclease activity |
Q43970148 | p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells |
Q40902865 | p53 and tumour viruses: catching the guardian off-guard |
Q48799379 | p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. |
Q77375941 | p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis |
Q42645736 | p53 is a general repressor of RNA polymerase III transcription |
Q77954392 | p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts |
Q40635072 | p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells |
Q41284102 | p53: guardian of cellular senescence |
Q36326866 | pRB plays an essential role in cell cycle arrest induced by DNA damage |
Search more.